Local Therapies for the Global COVID-19 Pandemic Blog Post
Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as a therapeutic option for COVID-19 patients.
The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access? Blog Post
このウェビナーでは、希少疾患治療薬の価格がどのように変化してきたか、そして価値に基づく価格設定を効果的に支援するための実践的なアプローチをご紹介します。
How to Demonstrate Virtual Bioequivalence for Complex Dermal Generic Drugs Blog Post
このウェビナーでは、サターラが PBPK Simcyp Simulator を拡張し、広範な皮膚モデルである MPML MechDermA（多相、多次元皮膚吸収モデル）を組み込んだ方法について説明します。
Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development Blog Post
Model-based Meta-analysis is a framework to compare drugs used to treat diabetic peripheral neuropathy, post-herpetic neuralgia & fibromyalgia.
ICER’s Unsupported Drug Price Increase Report: An Analysis Blog Post
We analyze the drug-price watchdog, ICER’s (Institute for Clinical and Economic Review) “Report on Unsupported Price Increases.”
Common Questions about Define-XML and the Stylesheet Blog Post
In this blog, we answer common questions about Define-XML and the Stylesheet, including all you need to know for study submission and what version to use.
Trends for Market Access, HEOR, and Real World Evidence Blog Post
This blog reviews trends for using health economics and outcomes research and real-world evidence to evaluate the value of medicines and health technologies.
